- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02044666
Cook Micronized Small Intestinal Submucosa (SIS) for Critical Limb Ischemia
January 5, 2017 updated by: Cook Group Incorporated
Pilot Safety Study of Micronized Small Intestinal Submucosa (SIS) for Critical Limb Ischemia
This study is intended to collect safety and effectiveness data on the Cook Micronized Small Intestinal Submucosa (SIS)
Study Overview
Status
Completed
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
10
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Ontario
-
Toronto, Ontario, Canada, M5G 1X6
- Toronto General Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
21 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Rutherford stage 4 or 5 or Leriche-Fontaine classification IIIB
- Patient is unable to be treated by endovascular or surgical means
Exclusion Criteria:
- Patient is pregnant or breastfeeding
- Patient has had a previous surgery within 30 days of the study procedure
- Patient has a planned surgical or interventional procedure within 30 days after the study procedure
- Patient has a life expectancy of less than 1 year
- Patient has a known allergy to pigs or pig products, or has a religious or cultural objection to the use of pig tissue.
- Additional restrictions as specified in the protocol
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Experimental: Treatment
|
Micronized Small Intestinal Submucosa (SIS)
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
---|---|
Frequency and types of adverse events
Time Frame: 180 days
|
180 days
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Kong Teng Tan, MD, Toronto General Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2014
Primary Completion (Actual)
March 1, 2016
Study Completion (Actual)
August 1, 2016
Study Registration Dates
First Submitted
January 22, 2014
First Submitted That Met QC Criteria
January 22, 2014
First Posted (Estimate)
January 24, 2014
Study Record Updates
Last Update Posted (Estimate)
January 6, 2017
Last Update Submitted That Met QC Criteria
January 5, 2017
Last Verified
January 1, 2017
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 13-004
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Ischemia
-
University Hospital, Strasbourg, FranceTerminatedVascular Surgery | Ischemia-reperfusion | Ischemia PreconditioningFrance
-
Beytepe Murat Erdi Eker State HospitalCompletedAnterior Segment Ischemia (Diagnosis)
-
University Hospital, Strasbourg, FranceCompletedSkeletal Muscle Ischemia | Severe Lower Limb Ischemia | Mitochondrial DysfunctionFrance
-
Egyptian Cerebro-Cardio-Vascular AssociationUnknownRisk Factor, Cardiovascular | Ischemia, Myocardial | Ischemia, Cerebral
-
The First Affiliated Hospital with Nanjing Medical...RecruitingHepatic IschemiaChina
-
Maastricht University Medical CenterUnknownIschemia-ReperfusionNetherlands
-
Technische Universität DresdenRecruitingRetinal IschemiaGermany
-
Centre Hospitalier Universitaire de NiceCompleted
-
Attikon HospitalUniversity Hospital of PatrasCompleted
-
Beth Israel Deaconess Medical CenterWithdrawn
Clinical Trials on Micronized Small Intestinal Submucosa (SIS)
-
Xiaoyong ZengEnrolling by invitationUrethral Stricture, MaleChina
-
Hamilton Health Sciences CorporationCanadian Institutes of Health Research (CIHR); DePuy Orthopaedics; London Health...Unknown
-
University of CalgaryCorMatrix Cardiovascular, Inc.CompletedHeart Failure | Acute Coronary SyndromeCanada
-
Ascension South East MichiganWithdrawnOtologic DiseaseUnited States
-
Asian Institute of Gastroenterology, IndiaRecruitingCrohn Disease | Magnetic Resonance Imaging | Ultrasound Therapy; Complications | Computed TomographyIndia
-
Shanghai 10th People's HospitalCompletedFecal Microbiota Transplantation | Intestinal Pseudo-ObstructionChina
-
Maastricht University Medical CenterZonMw: The Netherlands Organisation for Health Research and DevelopmentCompletedIrritable Bowel Syndrome | Colonic Diseases, Functional | Abdominal PainNetherlands
-
St. Antonius HospitalRecruitingAdolescent | Irritable Bowel Syndrome | Child | Adverse Drug Event | Therapeutics | Functional Abdominal Pain SyndromeNetherlands
-
AbbVie (prior sponsor, Abbott)Quintiles, Inc.CompletedAdvanced Parkinson's DiseaseUnited States, New Zealand